© Reuters. FILE PHOTO: People walk by a CVS Pharmacy store in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton
(Reuters) – CVS Health Corp (NYSE:) reported a 10.5% rise in first-quarter profit on Tuesday, helped in part by higher sales at its drug stores, with more customers seeking COVID-19 tests and vaccinations.
The company has been offering COVID-19 tests and vaccines as part of the ongoing federal program, which CVS hopes will increase footfall at its drug stores.
CVS Health’s net profit rose to $2.22 billion, or $1.68 per share, in the reported quarter, from $2.01 billion, or $1.53 per share, a year earlier.
Sales rose to $69.1 billion from $66.76 billion.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.